Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Diagnosoft unveiled its newest software solution: Diagnosoft SENC
Diagnosoft, Inc., an innovator in magnetic resonance (MR) image analysis software that assists in diagnosis, staging and therapeutic monitoring of cardiovascular disease, has unveiled its newest software solution: Diagnosoft SENC. Strain-encoding, or SENC, is a new MRI analysis technique that will help physicians measure regional contraction, or relaxation, of the heart’s myocardium. Like Diagnosoft’s other two software products, Diagnosoft HARP and Diagnosoft PLUS, SENC enables quantification of data to improve diagnosis and guide monitoring and treatment of coronary artery disease.

Developed by Dr. Nael Osman, a faculty member at Johns Hopkins University, SENC is now a proprietary product of Diagnosoft, Inc. According to Dr. Osman, co-founder of Diagnosoft, “SENC provides an objective way to assess regional variations in muscle contraction due to ischemia, myocardial infarction, or other causes. Moreover, SENC produces maps of regional function with high spatial resolution at a level of quality sufficient even for the thin wall of the right ventricle. As a result, the technique can reveal small regional anomalies in contractility within the wall.”

Most cardiac MRI procedures require patients to hold their breath. However, SENC images can be acquired in a fraction of a second, mapping regional function with unprecedented speed, so it can be used in combination with tests and maneuvers that allow patients to breathe normally. That means SENC is suitable for stress testing of cardiac function, as well as other diagnostic tests.

Dr. Osman said new Diagnosoft SENC is a great addition to a product suite originated with Diagnosoft HARP, the first FDA 510k-Cleared software designed for the analysis of tagged magnetic resonance images. “While MR tagged images can be produced on most MRI systems, the pulse sequence has limited spatial resolution and takes time to acquire. SENC does not require a second step of image processing, as does analyzing tagged MR images, so it streamlines throughput and decision-making.”

About Diagnosoft
Diagnosoft , Inc., based in North Carolina and California, is a privately held company specializing in image analysis software that assists in diagnosis, staging and therapeutic monitoring of cardiovascular disease. One of its products, Diagnosoft HARP, is distinguished as the first FDA 510k-Cleared software designed for the analysis of tagged magnetic resonance images. The company is focused on improving physician workflow, quantifying decision-making, and enhancing research and drug development advances. More information about the company’s three MRI analysis software products, Diagnosoft HARP, Diagnosoft Plus and new Diagnosoft SENC, is available at www.diagnosoft.com.

Source: Diagnosoft

You can discuss about Diagnosoft and its services in the Diagnosoft Company User Group